Administrative Supplements to Expand NCI-supported Community Outreach Capacity through Community Health Educators (CHE) of the National Outreach Network (NON)

项目摘要 南卡罗来纳州医科大学（MUSC）的霍林斯癌症中心（HCC）寻求更新其 国家癌症研究所（NCI）国家外展网络（NON CHE）再资助两年。作为 在我们目前资助的非CHE赠款中，具体目标是： 具体目标1。扩大、完善和评估MOVENUP循证、小组、社区 培训员癌症教育课程，重点是南卡罗来纳州农村I-95走廊的HPV疫苗接种率， 与SC的非洲卫理公会圣公会建立伙伴关系。 具体目标2。开展以癌症临床试验和生物标本采集为重点的教育课程， 参与MUSC-HCC的NCORP研究。（请注意，具体目标2的措辞发生了变化 略从：“进行癌症临床试验和生物标本收集为重点的教育会议与 在南卡罗来纳州MUSC-HCC的NCORP研究中心服务的患者。 具体目标3。在SC北部地区进行年度社区指南针。 在当前资助期间（2019年4月1日至2021年3月31日），我们的NON CHE计划达到342，700 SC 居民通过广播/电视/公共媒体发布与HPV、临床试验和COVID-19相关的公告 信息.我们为298名参与者提供了MOVENUP课程，他们完成了278项测试前/测试后调查 (92完成率）。所有278份完成的调查都被送到NCI进行分析。此外，我们还提到了77个 参加NCI的断层合成乳腺摄影成像筛查试验（TMIST）的参与者， NCI社区肿瘤学研究计划（NCORP）在MUSC-HCC的少数/服务不足站点。非 CHE更新补助金将为未来的校外资助铺平道路，以支持社区参与 本文所述的战略。由福特博士领导的MUSC-HCC COE坚定地致力于继续 利用其资金支持和维持高等教育委员会正在进行的活动。

PROJECT SUMMARY The Hollings Cancer Center (HCC) at the Medical University of South Carolina (MUSC) seeks renewal of its National Cancer Institute (NCI) National Outreach Network (NON CHE) funding for an additional two years. As in our currently funded NON CHE grant, the Specific Aims are: Specific Aim 1. Expand, refine and evaluate the MOVENUP evidence-based, small-group, community Train the Trainer cancer educational sessions to focus on HPV vaccination uptake in the rural I-95 Corridor of SC, in partnership with the African Methodist Episcopal Church of SC. Specific Aim 2. Conduct cancer clinical trial- and biospecimen collection-focused educational sessions to recruit participants to the MUSC-HCC’s NCORP studies. (Please note that the wording of Specific Aim 2 was changed slightly from: “Conduct cancer clinical trial- and biospecimen collection-focused educational sessions with the patients served at the MUSC-HCC’s NCORP sites in SC.”) Specific Aim 3. Conduct an Annual Community Compass in the SC Upstate Region. During the current funding period (April 1, 2019 – March 31, 2021), our NON CHE program reached 342,700 SC residents through radio/TV/public media announcements related to HPV, clinical trials, and COVID-19 information. We delivered MOVENUP sessions to 298 participants who completed 278 pre -test/post-test surveys (92% completion rate). All 278 completed surveys were sent to the NCI for analysis. Additionally, we referred 77 participants to the NCI’s Tomosynthesis Mammographic Imaging Screening Trial (TMIST) taking place at the NCI Community Oncology Research Program (NCORP) Minority/Underserved site at the MUSC -HCC. The NON CHE renewal grant will pave the way to future extramural funding to support the community engagement strategies described herein. The MUSC-HCC COE, led by Dr. Ford, is strongly committed to continuing to leverage its funding to support and sustain the ongoing activities of the CHE.